In addition, SULT1A1 and UGT1A1 act on both estrogens and catecholestrogens, and therefore the potential effects of combinations of many genotypes of phase I catecholestrogen genes and phase II detoxification genes may identify mechanisms by which multiple genotypes in common pathways may influence breast cancer risk. The gene discussed is SULT1A1; the disease is breast carcinoma.